Micron Medical To Showcase New Brand, Contract Manufacturing Capabilities At World's Largest Meeting Of Orthopaedic Surgeons And Allied Professions

FITCHBURG, Mass., March 23, 2015 /PRNewswire/ -- Micron Medical, a new division of Micron Products, Inc., a wholly owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT: HRT), will showcase its contract manufacturing capabilities and services designed to help orthopaedic OEMs bring products to market quickly, efficiently and with high value at a low cost. Micron Medical will be exhibiting at the AAOS Annual Meeting Booth 1357 March 25 27, 2015, at the Venetian/Sands EXPO, Las Vegas, Nevada.

"Micron Medical is looking forward to introducing its brand and capabilities to the orthopaedic surgery community," said Salvatore Emma, Jr., President and CEO. "As a medical device contract manufacturer that provides personalized and fully integrated services, we've built the Micron Medical brand to focus on producing innovative manufacturing methodologies that deliver speed, agility and the highest quality coupled with personalized service for our original equipment manufacturer (OEM) customers."

In addition to mass production of orthopaedic implant components, Micron Medical also has the unique capability to quickly and routinely produce personalized orthopaedic implant components that match patient-specific anatomies.

Among the products showcased by Micron Medical at its booth will be FDA-approved orthopaedic knee implants produced for New Era Orthopaedics, LLC, with which Micron Medical recently entered into an exclusive manufacturing agreement.

For more information, visit www.micronmedical.com.

About Micron Medical
Micron Medical, a division of Micron Products, Inc., a wholly owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT: HRT), is a diversified contract manufacturing organization that produces highly engineered, innovative medical device technologies requiring precision machining and injection molding. Micron Medical harnesses its engineering design expertise and reliable, proprietary manufacturing processes to partner with orthopaedic medical device OEMs to find opportunities and growth. Through its personalized, fully integrated approach to medical device contract manufacturing, Micron Medical offers OEMs responsive, adaptive, comprehensive and nimble production and processes.

About Arrhythmia Research Technology, Inc.
Arrhythmia Research Technology, Inc. ("ART"), through its wholly owned subsidiary, Micron Products, Inc., manufactures components, devices and equipment for medical, military, law enforcement, industrial and automotive applications. In addition, ART is a market leader in the production and sale of silver/silver chloride coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors.

For more information about ART or Micron Products, visit their websites:  www.arthrt.com and micronproducts.com

Safe Harbor Statement
Forward-looking statements made herein are based on current expectations of Arrhythmia Research Technology, Inc. ("ART"), and its wholly owned subsidiary Micron Products, Inc. ("Micron" and collectively with ART, "our" or the "Company") that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include our ability to retain order volumes from customers who represent significant proportions of net sales; our ability to maintain our pricing model, offset higher costs with price increases and/or decrease our cost of sales; variability of customer delivery requirements; the level of sales of higher margin products and services; our ability to renew our credit facility and manage our level of debt and provisions in the debt agreements which could make the Company sensitive to the effects of economic downturns and limit our ability to react to changes in the economy or our industry; failure to comply with financial and other covenants in our credit facility; volatility in commodity and energy prices and our ability to offset higher costs with price increases; continued availability of supplies or materials used in manufacturing at competitive prices; variability of customer delivery requirements; variations in the mix of products sold; and the amount and timing of investments in capital equipment, sales and marketing, engineering and information technology resources.  More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/micron-medical-to-showcase-new-brand-contract-manufacturing-capabilities-at-worlds-largest-meeting-of-orthopaedic-surgeons-and-allied-professions-300054313.html

SOURCE Micron Medical, a division of Micron Products, Inc.